Login / Signup

Safety, effectiveness, and complications of the first-in-human minimally invasive transthoracic ventricular septal defect closure using a bioabsorbable occluder: a cohort study with 12-month follow-up.

Qiang ZhangJing ZhouShanliang ZhuHao LiuYu MaoYing TangXuming MoJun Chen
Published in: Cardiovascular diagnosis and therapy (2024)
TEE-guided minimally invasive VSD occlusion using fully biodegradable occluders has the advantages of minimal trauma, high safety, and few complications, with satisfactory recent efficacy, and good prospects for clinical safety applications.
Keyphrases
  • minimally invasive
  • endothelial cells
  • risk factors
  • randomized controlled trial
  • heart failure
  • systematic review
  • drug delivery
  • current status
  • atrial fibrillation
  • pluripotent stem cells